Rethinking CNS disorders: Time for new drug targets?

Allan V. Kalueff*, Adam Michael Stewart, Irving I. Gottesman

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)491-492
Number of pages2
JournalTrends in Pharmacological Sciences
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 2014
Externally publishedYes

Cite this